SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-180149
Filing Date
2008-08-18
Accepted
2008-08-18 17:19:33
Documents
8
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 602658
2 ACCESS AGREEMENT dex101.htm EX-10.1 55620
3 EMPLOYMENT AGREEMENT dex102.htm EX-10.2 34334
4 CONSULTING AGREEMENT dex103.htm EX-10.3 15325
5 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION dex15.htm EX-15 2091
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6941
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7050
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 6268
  Complete submission text file 0001193125-08-180149.txt   731704
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 081025750
SIC: 2834 Pharmaceutical Preparations